168 related articles for article (PubMed ID: 15005735)
1. Increased expression of allergen-induced in vitro interleukin-10 and interleukin-18 mRNA in peripheral blood mononuclear cells of allergic rhinitis patients after specific immunotherapy.
Savolainen J; Laaksonen K; Rantio-Lehtimäki A; Terho EO
Clin Exp Allergy; 2004 Mar; 34(3):413-9. PubMed ID: 15005735
[TBL] [Abstract][Full Text] [Related]
2. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.
Savolainen J; Jacobsen L; Valovirta E
Allergy; 2006 Oct; 61(10):1184-90. PubMed ID: 16942566
[TBL] [Abstract][Full Text] [Related]
3. Allergen-induced in vitro expression of IL-18, SLAM and GATA-3 mRNA in PBMC during sublingual immunotherapy.
Savolainen J; Nieminen K; Laaksonen K; Laiho T; Jacobsen L; Lahesmaa R; Terho EO; Valovirta E
Allergy; 2007 Aug; 62(8):949-53. PubMed ID: 17620074
[TBL] [Abstract][Full Text] [Related]
4. Three-year follow-up study of allergen-induced in vitro cytokine and signalling lymphocytic activation molecule mRNA responses in peripheral blood mononuclear cells of allergic rhinitis patients undergoing specific immunotherapy.
Nieminen K; Laaksonen K; Savolainen J
Int Arch Allergy Immunol; 2009; 150(4):370-6. PubMed ID: 19571569
[TBL] [Abstract][Full Text] [Related]
5. In vitro allergen-induced mRNA expression of signaling lymphocytic activation molecule by PBMC of patients with allergic rhinitis is increased during specific pollen immunotherapy.
Laaksonen K; Junikka M; Lahesmaa R; Terho EO; Savolainen J
J Allergy Clin Immunol; 2003 Dec; 112(6):1171-7. PubMed ID: 14657878
[TBL] [Abstract][Full Text] [Related]
6. Allergen induced mRNA expression of interleukin-5, but not of interleukin-4 and interferon-gamma, in peripheral blood mononuclear cells obtained before the pollen season predicts the clinical efficacy of immunotherapy for seasonal allergic rhinitis.
Kakinoki Y; Ohashi Y; Nakai Y; Washio Y; Nasako Y; Tanaka A; Nakai Y
Scand J Immunol; 2000 Feb; 51(2):202-8. PubMed ID: 10652165
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome and IL-17, IL-23, IL-27 and FOXP3 expression in peripheral blood mononuclear cells of pollen-allergic children during sublingual immunotherapy.
Nieminen K; Valovirta E; Savolainen J
Pediatr Allergy Immunol; 2010 Feb; 21(1 Pt 2):e174-84. PubMed ID: 19566585
[TBL] [Abstract][Full Text] [Related]
8. Human leukocyte antigen-G and regulatory T cells during specific immunotherapy for pollen allergy.
Sørensen AE; Johnsen CR; Dalgaard LT; Würtzen PA; Kristensen B; Larsen MH; Ullum H; Søes-Petersen U; Hviid TV
Int Arch Allergy Immunol; 2013; 162(3):237-52. PubMed ID: 24022071
[TBL] [Abstract][Full Text] [Related]
9. Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1:Th2 cytokine ratios.
Wachholz PA; Nouri-Aria KT; Wilson DR; Walker SM; Verhoef A; Till SJ; Durham SR
Immunology; 2002 Jan; 105(1):56-62. PubMed ID: 11849315
[TBL] [Abstract][Full Text] [Related]
10. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y
Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414
[TBL] [Abstract][Full Text] [Related]
11. Cytokine production by peripheral blood mononuclear cells following birch-pollen immunotherapy.
Movérare R; Elfman L; Björnsson E; Stålenheim G
Immunol Lett; 2000 Jul; 73(1):51-6. PubMed ID: 10963811
[TBL] [Abstract][Full Text] [Related]
12. Effects of allergen-specific immunotherapy on functions of helper and regulatory T cells in patients with seasonal allergic rhinitis.
Kirmaz C; Ozenturk Kirgiz O; Bayrak P; Yilmaz O; Vatansever S; Ozbilgin K; Onur E; Celik O; Sogut A; Ay G; Yuksel H
Eur Cytokine Netw; 2011 Mar; 22(1):15-23. PubMed ID: 21421451
[TBL] [Abstract][Full Text] [Related]
13. Histamine type 2 receptor expression on peripheral blood regulatory lymphocytes in patients with allergic rhinitis treated with specific immunotherapy.
Ciebiada M; Kasztalska K; Gorska-Ciebiada M; Górski P
Am J Rhinol Allergy; 2014; 28(3):e130-5. PubMed ID: 24980224
[TBL] [Abstract][Full Text] [Related]
14. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
[TBL] [Abstract][Full Text] [Related]
15. Allergen induced cytokine profiles in type I allergic individuals before and after immunotherapy.
Söderlund A; Gabrielsson S; Paulie S; Hammarström ML; Rak S; Troye-Blomberg M
Immunol Lett; 1997 Jun; 57(1-3):177-81. PubMed ID: 9232448
[TBL] [Abstract][Full Text] [Related]
16. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
[TBL] [Abstract][Full Text] [Related]
17. In vitro kinetics of allergen- and microbe-induced IL-4 and IFN-gamma mRNA expression in PBMC of pollen-allergic patients.
Laaksonen K; Waris M; Mäkelä MJ; Terho EO; Savolainen J
Allergy; 2003 Jan; 58(1):62-6. PubMed ID: 12580809
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-16 inhibits interleukin-13 production by allergen-stimulated blood mononuclear cells.
El Bassam S; Pinsonneault S; Kornfeld H; Ren F; Menezes J; Laberge S
Immunology; 2006 Jan; 117(1):89-96. PubMed ID: 16423044
[TBL] [Abstract][Full Text] [Related]
19. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.
Bellinghausen I; Metz G; Enk AH; Christmann S; Knop J; Saloga J
Eur J Immunol; 1997 May; 27(5):1131-9. PubMed ID: 9174602
[TBL] [Abstract][Full Text] [Related]
20. Changes in cytokine production in vitro during the early phase of birch-pollen immunotherapy.
Movérare R; Elfman L; Björnsson E; Stâlenheim G
Scand J Immunol; 2000 Aug; 52(2):200-6. PubMed ID: 10931388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
